The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.
Jansen Jab Gets The EMA’s Go Ahead
The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...
09.41 21 Apr 2021
Read more about
Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast VaccineRelated Episodes